Central compartment dissection for well differentiated thyroid cancer... and the band plays on

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 19, Issue 2, 2011, Pages 106-112

  Iyer, N Gopalakrishna ^a   Shaha, Ashok R ^b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

central node dissection; Delphian; pretracheal; tracheo esophageal groove

Indexed keywords

CANCER CELL; CANCER EPIDEMIOLOGY; CANCER SURGERY; CELL DIFFERENTIATION; CLINICAL EVALUATION; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NECK DISSECTION; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL ANATOMY; THYROID CANCER;

DISEASE PROGRESSION; FROZEN SECTIONS; HUMANS; LYMPHATIC METASTASIS; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; REOPERATION; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 79953837276     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e328343af58     Document Type: Review

References (49)

1. Dos Santos Silva I, Swerdlow AJ. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 1993; 67:330-340. (Pubitemid 23049558)
2. Pettersson B, Adami HO, Wilander E, et al. Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type. Int J Cancer 1991; 48:28-33.
3. Iyer NG, Shaha AR, Silver CE, et al. Thyroid incidentalomas: to treat or not to treat. Eur Arch Otorhinolaryngol 2010; 267:1019-1026.
4. Iyer NG, Shaha AR. Management of thyroid nodules and surgery for differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 2010; 22:405-412.
5. Clayman GL, Shellenberger TD, Ginsberg LE, et al. Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 2009; 31:1152-1163.
6. Mazzaferri EL, Doherty GM, Steward DL. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 2009; 19:683-689. This debate summarizes the polarized view in the thyroid surgical community regarding the role of prophylactic central compartment dissections. It provides an excellent summary of the existing data and insights into the expert opinion that surrounds the controversy.
7. Sugitani I, Fujimoto Y, Yamada K, et al. Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg 2008; 32:2494-2502.
8. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16:109-142.
9. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167-1214. The latest edition of the ATA guidelines provides a succinct account of the existing data and level of evidence to support recommendations regarding the management of differentiated thyroid cancer. Central compartment dissection is one of the key topics discussed and re-examined in the wake of the controversy generated from the first edition of these guidelines.
10. Grodski S, Cornford L, Sywak M, et al. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg 2007; 77:203-208. (Pubitemid 46411656)
11. Carty SE, Cooper DS, Doherty GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009; 19:1153-1158.
12. Isaacs JD, Lundgren CI, Sidhu SB, et al. The Delphian lymph node in thyroid cancer. Ann Surg 2008; 247:477-482.
13. Iyer NG, Shaha AR, Ferlito A, et al. Delphian node metastasis in head and neck cancers: oracle or myth? J Surg Oncol 2010; 102:354-358.
14. Arturi F, Russo D, Giuffrida D, et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 1997; 82:1638-1641. (Pubitemid 27200449)
15. Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002; 26: 22-28. (Pubitemid 36918813)
16. Shaha A. Treatment of thyroid cancer based on risk groups. J Surg Oncol 2006; 94:683-691. (Pubitemid 44902067)
17. Tuttle RM, Leboeuf R, Shaha AR. Medical management of thyroid cancer: a risk adapted approach. J Surg Oncol 2008; 97:712-716. (Pubitemid 351812974)
18. Hughes CJ, Shaha AR, Shah JP, et al. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996; 18:127-132. (Pubitemid 26075352)
19. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104:947-953. (Pubitemid 19011971)
20. Sugitani I, Kasai N, Fujimoto Y, et al. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004; 135:139-148. (Pubitemid 38130764)
21. Podnos YD, Smith D, Wagman LD, et al. The implication of lymph node metastasis on survival in patients with well differentiated thyroid cancer. Am Surg 2005; 71:731-734.
22. Zaydfudim V, Feurer ID, Griffin MR, et al. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008; 144:1070-1077; discussion 1077-1078.
23. Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005; 90:5723-5729. (Pubitemid 41415482)
24. Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003; 134:946-954; discussion 954-955.
25. Marshall CL, Lee JE, Xing Y, et al. Routine preoperative ultrasonography for papillary thyroid cancer: effects on cervical recurrence. Surgery 2009; 146:1063-1072. Articles such as this (and the previous one) show why preoperative ultrasound should become the standard of care, as it has significant impact on management decisions.
26. Machens A, Hauptmann S, Dralle H. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery 2009; 145:176-181.
27. Shen WT, Ogawa L, Ruan D, et al. Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. Surgery 2010; 148:398-403.
28. Monchik JM, Simon CJ, Caragacianu DL, et al. Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid? Surgery 2009; 146:1182-1187.
29. Randolph GW, Pearce EN. Surgery of well differentiated thyroid carcinoma: the pendulum swings back in the central neck. Endocr Pract 2010; 16:1-16.
30. Sywak M, Cornford L, Roach P, et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006; 140:1000-1005; discussion 1005-1007.
31. Hughes DT, White ML, Gauger PG, et al. Routine central lymph node dissection for papillary thyroid cancer. Surgery 2010; 148:1100-1106; discussion 1006-1007.
32. Shaha AR. Revision thyroid surgery-technical considerations. Otolaryngol Clin North Am 2008; 41:1169-1183; x.
33. Iyer NG, Shaha AR. Complications of thyroid surgery: prevention and management. Minerva Chir 2010; 65:71-82.
34. Tisell LE, Nilsson B, Molne J, et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 1996; 20:854-859. (Pubitemid 26281914)
35. Salvesen H, Njolstad PR, Akslen LA, et al. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg 1992; 158:583-589. (Pubitemid 23025711)
36. Kukkonen ST, Haapiainen RK, Franssila KO, et al. Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients. World J Surg 1990; 14:837-841; discussion 841-842.
37. Scheumann GF, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994; 18:559-567; discussion 567-568.
38. Noguchi S, Murakami N, Yamashita H, et al. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 1998; 133:276-280. (Pubitemid 28154989)
39. Shah MD, Hall FT, Eski SJ, et al. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 2003; 113:2102-2107. (Pubitemid 38063829)
40. Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 2007; 245:604-610. (Pubitemid 46555665)
41. Steinmuller T, Klupp J, Rayes N, et al. Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 2000; 166:29-33. (Pubitemid 30062584)
42. Bardet S, Malville E, Rame JP, et al.Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol 2008; 158:551-560. (Pubitemid 351606351)
43. Shindo M, Wu JC, Park EE, et al. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 2006; 132:650-654. (Pubitemid 43927043)
44. Pereira JA, Jimeno J, Miquel J, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 2005; 138:1095-1100; discussion 1100-1101.
45. Rubino C, de Vathaire F, Dottorini ME, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003; 89:1638-1644. (Pubitemid 37464133)
46. Ross DS, Litofsky D, Ain KB, et al. Recurrence after treatment of micropapillary thyroid cancer. Thyroid 2009; 19:1043-1048.
47. Hay ID. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol 2006; 94:692-700. (Pubitemid 44902068)
48. Shah JP. Head and neck surgery and oncology. 3rd ed. New York, USA: Mosby; 2003.
49. Giles Senyurek Y, Tunca F, Boztepe H, et al. The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection. Surgery 2009; 146:1188-1195.